Posted by Michael Wonder on 23 Jul 2023
How a drug maker profited by slow walking a promising HIV therapy
22 July 2023 - Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show.
David Swisher is among the people suing Gilead. He took the company’s HIV drug Truvada for 12 years and developed kidney disease and osteoporosis.
